{"entity":{"type":"insider","cik":"0002022087","url":"/insider/0002022087","json_url":"/insider/0002022087.json","name":"Bredt David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":13,"first":"2025-03-17","last":"2026-02-19","span_basis":"filed_date"},"name_variants":[{"name":"Bredt David","source":"filing","n_filings":13,"first_seen":"2025-03-17","last_seen":"2026-02-19"}],"transactions":[{"id":5745313,"accession":"0001193125-26-059883","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-059883","line_url":"/filing/0001193125-26-059883","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":29.01824117647059,"price_display":"29.02","price_state":"stated","total_value":246655.05,"total_display":"246,655.05","total_whole":"246,655","shares_owned_after":389275.0,"shares_owned_after_display":"389,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider","n_lines":3},{"id":5762121,"accession":"0001193125-26-015350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-015350","line_url":"/filing/0001193125-26-015350","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":26.839017647058824,"price_display":"26.84","price_state":"stated","total_value":228131.65,"total_display":"228,131.65","total_whole":"228,132","shares_owned_after":395775.0,"shares_owned_after_display":"395,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-16","scope":"insider","n_lines":2},{"id":5821991,"accession":"0001193125-26-002470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-002470","line_url":"/filing/0001193125-26-002470#line-2","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6567.0,"shares_display":"6,567","price_per_share":30.0499,"price_display":"30.05","price_state":"stated","total_value":197337.6933,"total_display":"197,337.69","total_whole":"197,338","shares_owned_after":404075.0,"shares_owned_after_display":"404,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-31","filed_date":"2026-01-05","scope":"insider"},{"id":4532269,"accession":"0001193125-25-321142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-321142","line_url":"/filing/0001193125-25-321142","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":30.015290447058824,"price_display":"30.02","price_state":"stated","total_value":255129.9688,"total_display":"255,129.97","total_whole":"255,130","shares_owned_after":393438.0,"shares_owned_after_display":"393,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider","n_lines":2},{"id":4456627,"accession":"0001193125-25-286212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-286212","line_url":"/filing/0001193125-25-286212","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":25.18713425882353,"price_display":"25.19","price_state":"stated","total_value":214090.6412,"total_display":"214,090.64","total_whole":"214,091","shares_owned_after":401142.0,"shares_owned_after_display":"401,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider","n_lines":2},{"id":4754991,"accession":"0001193125-25-241475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-241475","line_url":"/filing/0001193125-25-241475","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":25.787789223529412,"price_display":"25.79","price_state":"stated","total_value":219196.2084,"total_display":"219,196.21","total_whole":"219,196","shares_owned_after":410724.0,"shares_owned_after_display":"410,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-16","scope":"insider","n_lines":2},{"id":5069213,"accession":"0001193125-25-206203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-206203","line_url":"/filing/0001193125-25-206203","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":24.193962164705884,"price_display":"24.19","price_state":"stated","total_value":205648.6784,"total_display":"205,648.68","total_whole":"205,649","shares_owned_after":421544.0,"shares_owned_after_display":"421,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-17","scope":"insider","n_lines":2},{"id":5159510,"accession":"0000950170-25-109838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-109838","line_url":"/filing/0000950170-25-109838","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":14.996031764705883,"price_display":"15.00","price_state":"stated","total_value":127466.27,"total_display":"127,466.27","total_whole":"127,466","shares_owned_after":426842.0,"shares_owned_after_display":"426,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-18","scope":"insider","n_lines":2},{"id":4313799,"accession":"0000950170-25-096268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-096268","line_url":"/filing/0000950170-25-096268#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":13.9955,"price_display":"14.00","price_state":"stated","total_value":118961.75,"total_display":"118,961.75","total_whole":"118,962","shares_owned_after":435142.0,"shares_owned_after_display":"435,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-16","scope":"insider"},{"id":4048803,"accession":"0000950170-25-087897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-087897","line_url":"/filing/0000950170-25-087897#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":11.0026,"price_display":"11.00","price_state":"stated","total_value":93522.1,"total_display":"93,522.10","total_whole":"93,522","shares_owned_after":443642.0,"shares_owned_after_display":"443,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":4027621,"accession":"0000950170-25-074409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-074409","line_url":"/filing/0000950170-25-074409#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":9.5602,"price_display":"9.56","price_state":"stated","total_value":81261.7,"total_display":"81,261.70","total_whole":"81,262","shares_owned_after":452142.0,"shares_owned_after_display":"452,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4417625,"accession":"0000950170-25-054819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-054819","line_url":"/filing/0000950170-25-054819#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":9.5659,"price_display":"9.57","price_state":"stated","total_value":81310.15,"total_display":"81,310.15","total_whole":"81,310","shares_owned_after":460642.0,"shares_owned_after_display":"460,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-15","filed_date":"2025-04-16","scope":"insider"},{"id":4059561,"accession":"0000950170-25-040447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-040447","line_url":"/filing/0000950170-25-040447#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022087","owner_name":"Bredt David","owner_display_name":"Bredt David","owner_url":"/insider/0002022087","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":10.8477,"price_display":"10.85","price_state":"stated","total_value":92205.45,"total_display":"92,205.45","total_whole":"92,205","shares_owned_after":469142.0,"shares_owned_after_display":"469,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002012593","name":"Rapport Therapeutics, Inc.","url":"/issuer/0002012593","role":"Officer (Chief Scientific Officer)","n_filings":13,"first_seen":"2025-03-17","last_seen":"2026-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002022087","retrieved_at":"2026-08-23T11:17:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}